PDB Short entry for 1SNU HEADER TRANSFERASE 12-MAR-04 1SNU TITLE CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE TITLE 2 KINASE CATALYTIC DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC KINASE DOMAIN; COMPND 5 SYNONYM: T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE LYK, KINASE COMPND 6 EMT; COMPND 7 EC: 2.7.1.112; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITK, LYK, EMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, IMMUNOLOGY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.BROWN,J.M.LONG,S.C.VIAL,N.DEDI,N.J.DUNSTER,S.B.RENWICK,A.J.TANNER, AUTHOR 2 J.D.FRANTZ,M.A.FLEMING,G.M.T.CHEETHAM REVDAT 4 23-AUG-23 1SNU 1 REMARK REVDAT 3 24-FEB-09 1SNU 1 VERSN REVDAT 2 25-JAN-05 1SNU 1 AUTHOR JRNL REVDAT 1 20-JUL-04 1SNU 0 JRNL AUTH K.BROWN,J.M.LONG,S.C.VIAL,N.DEDI,N.J.DUNSTER,S.B.RENWICK, JRNL AUTH 2 A.J.TANNER,J.D.FRANTZ,M.A.FLEMING,G.M.CHEETHAM JRNL TITL CRYSTAL STRUCTURES OF INTERLEUKIN-2 TYROSINE KINASE AND JRNL TITL 2 THEIR IMPLICATIONS FOR THE DESIGN OF SELECTIVE INHIBITORS. JRNL REF J.BIOL.CHEM. V. 279 18727 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 14766749 JRNL DOI 10.1074/JBC.M400031200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 72.4 REMARK 3 NUMBER OF REFLECTIONS : 18037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 620 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 22753 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 197 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.021 REMARK 3 BOND ANGLES (DEGREES) : 2.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-04. REMARK 100 THE DEPOSITION ID IS D_1000021859. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22753 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.5 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : 0.07400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.0 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.29600 REMARK 200 R SYM FOR SHELL (I) : 0.30100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1SM2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, SODIUM CITRATE, REMARK 280 MAGNESIUM ACETATE, DTT, PH 5.7, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.20000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.20000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 503 REMARK 465 THR A 504 REMARK 465 ARG A 505 REMARK 465 PHE A 506 REMARK 465 VAL A 507 REMARK 465 LEU A 508 REMARK 465 ASP A 509 REMARK 465 ASP A 510 REMARK 465 GLN A 511 REMARK 465 TYR A 512 REMARK 465 THR A 513 REMARK 465 SER A 514 REMARK 465 SER A 515 REMARK 465 THR A 516 REMARK 465 GLY A 517 REMARK 465 THR A 518 REMARK 465 LYS A 519 REMARK 465 PHE A 520 REMARK 465 LEU A 620 REMARK 465 VAL B 357 REMARK 465 GLY B 502 REMARK 465 MET B 503 REMARK 465 THR B 504 REMARK 465 ARG B 505 REMARK 465 PHE B 506 REMARK 465 VAL B 507 REMARK 465 LEU B 508 REMARK 465 ASP B 509 REMARK 465 ASP B 510 REMARK 465 GLN B 511 REMARK 465 TYR B 512 REMARK 465 THR B 513 REMARK 465 SER B 514 REMARK 465 SER B 515 REMARK 465 THR B 516 REMARK 465 GLY B 517 REMARK 465 THR B 518 REMARK 465 LYS B 519 REMARK 465 PHE B 520 REMARK 465 SER B 618 REMARK 465 GLY B 619 REMARK 465 LEU B 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 565 O HOH B 67 2.16 REMARK 500 OG1 THR B 392 O HOH B 36 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 408 OE2 GLU A 408 2555 1.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE B 530 CB - CA - C ANGL. DEV. = -12.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 361 80.25 -58.40 REMARK 500 SER A 371 -159.40 -119.80 REMARK 500 PHE A 374 19.39 151.55 REMARK 500 ASN A 384 -53.49 75.15 REMARK 500 LYS A 385 -11.57 -45.63 REMARK 500 ILE A 393 -80.58 -95.25 REMARK 500 ARG A 394 -109.61 158.49 REMARK 500 GLU A 395 -52.86 -151.18 REMARK 500 GLU A 427 32.81 -70.90 REMARK 500 GLN A 428 178.19 73.69 REMARK 500 ALA A 429 -179.44 81.06 REMARK 500 PRO A 430 108.30 -48.78 REMARK 500 GLU A 439 -1.10 -54.27 REMARK 500 ARG A 481 37.05 -72.70 REMARK 500 ASP A 482 54.66 178.17 REMARK 500 GLU A 492 75.57 -34.38 REMARK 500 ASN A 493 83.88 59.34 REMARK 500 GLN A 494 -27.10 65.65 REMARK 500 SER A 499 -147.07 -121.03 REMARK 500 ASP A 500 19.77 39.99 REMARK 500 ARG A 534 78.41 -113.19 REMARK 500 SER A 536 -47.17 -170.73 REMARK 500 SER A 537 -20.56 137.96 REMARK 500 GLU A 566 -36.63 -138.91 REMARK 500 SER A 618 -99.27 109.11 REMARK 500 ASP B 359 97.18 57.73 REMARK 500 SER B 361 71.73 -63.08 REMARK 500 GLN B 373 38.28 6.60 REMARK 500 PHE B 374 -12.27 -154.49 REMARK 500 ASN B 384 19.90 50.17 REMARK 500 ILE B 393 -113.04 -76.37 REMARK 500 ARG B 394 167.10 166.35 REMARK 500 SER B 414 127.42 -171.00 REMARK 500 GLN B 428 179.49 98.29 REMARK 500 ALA B 429 -163.36 83.23 REMARK 500 PRO B 430 108.28 -57.35 REMARK 500 GLU B 439 18.01 -53.22 REMARK 500 GLN B 450 8.71 81.79 REMARK 500 ARG B 451 174.01 -56.29 REMARK 500 GLU B 457 3.06 -63.21 REMARK 500 ARG B 481 21.34 -69.16 REMARK 500 ASP B 482 57.65 -174.34 REMARK 500 GLU B 492 74.04 -38.94 REMARK 500 ASN B 493 77.23 63.94 REMARK 500 SER B 533 53.06 27.49 REMARK 500 ASN B 561 45.57 -70.55 REMARK 500 ALA B 616 -14.30 -177.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STU A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE STU B 621 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SM2 RELATED DB: PDB REMARK 900 PHOSPHORYLATED INTERLEUKIN-2 KINASE CATALYTIC DOMAIN REMARK 900 RELATED ID: 1SNX RELATED DB: PDB REMARK 900 APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN DBREF 1SNU A 357 620 UNP Q08881 ITK_HUMAN 357 620 DBREF 1SNU B 357 620 UNP Q08881 ITK_HUMAN 357 620 SEQRES 1 A 264 VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN GLU ILE SEQRES 2 A 264 GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY TYR TRP SEQRES 3 A 264 LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE ARG GLU SEQRES 4 A 264 GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU ALA GLU SEQRES 5 A 264 VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL GLN LEU SEQRES 6 A 264 TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS LEU VAL SEQRES 7 A 264 PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP TYR LEU SEQRES 8 A 264 ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR LEU LEU SEQRES 9 A 264 GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA TYR LEU SEQRES 10 A 264 GLU GLU ALA CYS VAL ILE HIS ARG ASP LEU ALA ALA ARG SEQRES 11 A 264 ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS VAL SER SEQRES 12 A 264 ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP GLN TYR SEQRES 13 A 264 THR SER SER THR GLY THR LYS PHE PRO VAL LYS TRP ALA SEQRES 14 A 264 SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SER LYS SEQRES 15 A 264 SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP GLU VAL SEQRES 16 A 264 PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SER ASN SEQRES 17 A 264 SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE ARG LEU SEQRES 18 A 264 TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR GLN ILE SEQRES 19 A 264 MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP ARG PRO SEQRES 20 A 264 ALA PHE SER ARG LEU LEU ARG GLN LEU ALA GLU ILE ALA SEQRES 21 A 264 GLU SER GLY LEU SEQRES 1 B 264 VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN GLU ILE SEQRES 2 B 264 GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY TYR TRP SEQRES 3 B 264 LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE ARG GLU SEQRES 4 B 264 GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU ALA GLU SEQRES 5 B 264 VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL GLN LEU SEQRES 6 B 264 TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS LEU VAL SEQRES 7 B 264 PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP TYR LEU SEQRES 8 B 264 ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR LEU LEU SEQRES 9 B 264 GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA TYR LEU SEQRES 10 B 264 GLU GLU ALA CYS VAL ILE HIS ARG ASP LEU ALA ALA ARG SEQRES 11 B 264 ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS VAL SER SEQRES 12 B 264 ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP GLN TYR SEQRES 13 B 264 THR SER SER THR GLY THR LYS PHE PRO VAL LYS TRP ALA SEQRES 14 B 264 SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SER LYS SEQRES 15 B 264 SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP GLU VAL SEQRES 16 B 264 PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SER ASN SEQRES 17 B 264 SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE ARG LEU SEQRES 18 B 264 TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR GLN ILE SEQRES 19 B 264 MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP ARG PRO SEQRES 20 B 264 ALA PHE SER ARG LEU LEU ARG GLN LEU ALA GLU ILE ALA SEQRES 21 B 264 GLU SER GLY LEU HET STU A 301 35 HET STU B 621 35 HETNAM STU STAUROSPORINE FORMUL 3 STU 2(C28 H26 N4 O3) FORMUL 5 HOH *197(H2 O) HELIX 1 1 SER A 399 LEU A 413 1 15 HELIX 2 2 CYS A 442 THR A 449 1 8 HELIX 3 3 ALA A 455 ALA A 476 1 22 HELIX 4 4 ALA A 484 ARG A 486 5 3 HELIX 5 5 GLU A 492 GLN A 494 5 3 HELIX 6 6 SER A 526 SER A 531 1 6 HELIX 7 7 SER A 536 SER A 553 1 18 HELIX 8 8 SER A 563 THR A 573 1 11 HELIX 9 9 SER A 584 TRP A 595 1 12 HELIX 10 10 ARG A 598 ARG A 602 5 5 HELIX 11 11 ALA A 604 GLY A 619 1 16 HELIX 12 12 SER B 399 MET B 411 1 13 HELIX 13 13 CYS B 442 THR B 449 1 8 HELIX 14 14 ALA B 455 ALA B 476 1 22 HELIX 15 15 ALA B 484 ARG B 486 5 3 HELIX 16 16 PRO B 521 ALA B 525 5 5 HELIX 17 17 SER B 526 SER B 531 1 6 HELIX 18 18 SER B 536 SER B 553 1 18 HELIX 19 19 SER B 563 GLY B 574 1 12 HELIX 20 20 SER B 584 TRP B 595 1 12 HELIX 21 21 ARG B 598 ARG B 602 5 5 HELIX 22 22 ALA B 604 ILE B 615 1 12 SHEET 1 A 5 LEU A 363 GLY A 370 0 SHEET 2 A 5 VAL A 377 TRP A 382 -1 O VAL A 377 N ILE A 369 SHEET 3 A 5 ASP A 386 THR A 392 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 CYS A 432 GLU A 436 -1 O PHE A 435 N ALA A 389 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N TYR A 422 O VAL A 434 SHEET 1 B 2 CYS A 488 VAL A 490 0 SHEET 2 B 2 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 SHEET 1 C 5 LEU B 363 GLY B 372 0 SHEET 2 C 5 GLY B 375 TRP B 382 -1 O LEU B 379 N GLN B 367 SHEET 3 C 5 ASP B 386 THR B 392 -1 O THR B 392 N LEU B 376 SHEET 4 C 5 CYS B 432 GLU B 436 -1 O LEU B 433 N LYS B 391 SHEET 5 C 5 LEU B 421 CYS B 425 -1 N TYR B 422 O VAL B 434 SHEET 1 D 2 CYS B 488 VAL B 490 0 SHEET 2 D 2 ILE B 496 VAL B 498 -1 O LYS B 497 N LEU B 489 SITE 1 AC1 16 HOH A 176 ILE A 369 ALA A 389 LYS A 391 SITE 2 AC1 16 PHE A 435 GLU A 436 PHE A 437 MET A 438 SITE 3 AC1 16 GLY A 441 CYS A 442 ARG A 486 LEU A 489 SITE 4 AC1 16 SER A 499 ASP A 500 HOH B 42 PHE B 365 SITE 1 AC2 16 ILE B 369 GLY B 370 VAL B 377 ALA B 389 SITE 2 AC2 16 LYS B 391 PHE B 435 GLU B 436 PHE B 437 SITE 3 AC2 16 MET B 438 GLY B 441 CYS B 442 ARG B 486 SITE 4 AC2 16 ASN B 487 LEU B 489 SER B 499 ASP B 500 CRYST1 124.400 74.200 78.800 90.00 94.00 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007994 0.000000 0.000545 0.00000 SCALE2 0.000000 0.013441 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012704 0.00000